Infectious diseases remain one of the major risks to global public health and affect many communities worldwide. Prevention, control, and cure strategies make up the major handling mechanisms of infectious diseases.
This session will delve into recent advances and evidence-based interventions to impact on incidence of infectious diseases through outbreak management and improvement in outcomes through curative interventions.
Thereby, the approach of preventing infectious diseases is fundamentally from minimizing the risk of transmission. Various strategies include vaccination programs, public health campaigns, and personal hygiene practices, and all protect the population against this infection through healthy indications and prevention measures.
Advanced research improves the efficiency of vaccines and develops new prophylactic treatments that can be used to protect the most vulnerable population against a new pathogen. Good control measures will only be beneficial in the prevention of, and transmission of diseases into higher epidemic occurrences.
The installation of speedy diagnostic apparatus, tracing contacts, following a proper quarantine protocol, and prescription of treatment plans would greatly reduce infectious disease spillage.
Surveillances that chart infection trends would be important in taking actions on time with the allocation of resources during public health emergencies. The eradication of infectious diseases has actually become a central objective, particularly with drug-resistant pathogens and decreased mortality.
The treatment of infectious diseases requires a multidisciplinary approach by either pharmacological intervention, supportive therapies, or a modernization of new antimicrobial agents.
New discoveries in the field of personalized medicine have led to targeted therapies and immune modulation, which have increasingly come with better options for handling treatment.
A variety of participants will discuss how elements of prevention, control, and cure might be integrated to address some of the existing and emerging infectious disease threats.